⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Akceso Advisors AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Akceso Advisors AG
↗Basel, Switzerland
Akceso Advisors AG is a leading independent global advisory firm headquartered in Basel, Switzerland. Founded in 2011, the company specializes in market access, pricing, reimbursement strategy, operations, and policy-setting for life-science companies and regulatory authorities.
The firm provides evidence-based asset valuation, payer-relevant input for clinical development plans, and negotiation training. They utilize proprietary tools such as the Verity suite (Prices & Reimbursement, Analogues Wizard, Approvals, Managed Entry Agreements, Tender Management, and Marketscout) to support pharmaceutical and biotech clients in optimizing product launches and patient access.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Market Access & Pricing Consulting
SIZE & FINANCIALS
Employees:1-50
Founded:2011
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Global network of specialist service providers in Health Economics, Clinical Research, and Public Affairs.
COMPETITION
Position:Niche Player
Competitors:Genesis Research Group, Amiculum, Dice Medical Communications
LEADERSHIP
Key Executives:
Andras Incze - CEO, Founder, and Chairman
Dr. Seng Chin Mah - Board Member
Board Members:Andras Incze, Dr. Seng Chin Mah
LINKS
Website:akceso.ch
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Akceso Advisors AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.